Welcome to D3 Pharma
D3 Pharma is a privately owned specialty pharmaceutical company based in the United Kingdom.
It is committed to the research, development and commercialisation of licensed high-strength vitamin D medicinal products for the treatment of vitamin D deficiency, insufficiency and associated conditions.
D3 Pharma’s pioneering work in the vitamin D deficiency area aims to address a significant unmet need and improve product access in the UK, Europe and worldwide. Our goal is to provide physicians, nutritionists and other healthcare professionals with high-quality, high-strength, clinically effective vitamin D3 products that can be used to provide rapid repletion and maintenance of vitamin D levels in both children and adults. Our high-strength product range (Plenachol) will include vitamin D3 (cholecalciferol) at oral doses of 20,000 and 40,000 International Units (IU).
For information regarding D3 Pharma's product supply, please e-mail email@example.com
19 June 2012
D3 Pharma Limited today announces its continuing partnership with Encap Drug Delivery to expedite the commercial manufacturing and product licensing programme for its proprietary high-dose oral vitamin D3 product, Plenachol, for the treatment of vitamin D deficiency and insufficiency. Plenachol is a patented liquid-filled capsule formulation of vitamin D3 which was developed in conjunction with Encap and is available at two dose-strengths: 20,000 and 40,000 units.